DaVita Begin Period Cash Flow vs Change To Netincome Analysis
DVA Stock | USD 166.17 0.54 0.33% |
DaVita HealthCare financial indicator trend analysis is much more than just examining DaVita HealthCare latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether DaVita HealthCare is a good investment. Please check the relationship between DaVita HealthCare Begin Period Cash Flow and its Change To Netincome accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DaVita HealthCare Partners. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
Begin Period Cash Flow vs Change To Netincome
Begin Period Cash Flow vs Change To Netincome Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of DaVita HealthCare Begin Period Cash Flow account and Change To Netincome. At this time, the significance of the direction appears to have very week relationship.
The correlation between DaVita HealthCare's Begin Period Cash Flow and Change To Netincome is 0.21. Overlapping area represents the amount of variation of Begin Period Cash Flow that can explain the historical movement of Change To Netincome in the same time period over historical financial statements of DaVita HealthCare Partners, assuming nothing else is changed. The correlation between historical values of DaVita HealthCare's Begin Period Cash Flow and Change To Netincome is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Begin Period Cash Flow of DaVita HealthCare Partners are associated (or correlated) with its Change To Netincome. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Change To Netincome has no effect on the direction of Begin Period Cash Flow i.e., DaVita HealthCare's Begin Period Cash Flow and Change To Netincome go up and down completely randomly.
Correlation Coefficient | 0.21 |
Relationship Direction | Positive |
Relationship Strength | Very Weak |
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Change To Netincome
Most indicators from DaVita HealthCare's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into DaVita HealthCare current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DaVita HealthCare Partners. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. At present, DaVita HealthCare's Discontinued Operations is projected to increase significantly based on the last few years of reporting. The current year's Tax Provision is expected to grow to about 235.8 M, whereas Selling General Administrative is forecasted to decline to about 797.4 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 3.6B | 3.4B | 3.8B | 2.1B | Total Revenue | 11.6B | 11.6B | 12.1B | 7.1B |
DaVita HealthCare fundamental ratios Correlations
Click cells to compare fundamentals
DaVita HealthCare Account Relationship Matchups
High Positive Relationship
High Negative Relationship
DaVita HealthCare fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 17.3B | 17.0B | 17.1B | 16.9B | 16.9B | 10.2B | |
Short Long Term Debt Total | 11.2B | 11.2B | 12.0B | 11.8B | 11.1B | 5.7B | |
Other Current Liab | 756.2M | 1.5B | 1.4B | 1.5B | 1.6B | 1.7B | |
Total Current Liabilities | 2.4B | 2.5B | 2.4B | 2.6B | 2.6B | 1.6B | |
Total Stockholder Equity | 2.1B | 1.4B | 755.5M | 712.3M | 1.1B | 1.9B | |
Property Plant And Equipment Net | 6.3B | 6.4B | 6.3B | 5.9B | 5.6B | 5.9B | |
Net Debt | 10.1B | 10.9B | 11.5B | 11.6B | 10.7B | 11.3B | |
Retained Earnings | 1.4B | 852.5M | 354.3M | 174.5M | 598.3M | 568.4M | |
Accounts Payable | 403.8M | 434.3M | 402.0M | 479.8M | 514.5M | 284.0M | |
Cash | 1.1B | 325.0M | 461.9M | 244.1M | 380.1M | 450.3M | |
Non Current Assets Total | 13.6B | 13.8B | 14.0B | 13.8B | 13.8B | 7.6B | |
Non Currrent Assets Other | (461.6M) | (730.1M) | (694.3M) | (467.2M) | 271.3M | 284.8M | |
Cash And Short Term Investments | 1.1B | 345.1M | 484.2M | 321.8M | 391.7M | 501.7M | |
Net Receivables | 2.3B | 2.4B | 2.4B | 2.6B | 2.4B | 1.4B | |
Common Stock Shares Outstanding | 153.8M | 122.6M | 109.9M | 95.8M | 93.2M | 149.6M | |
Liabilities And Stockholders Equity | 17.3B | 17.0B | 17.1B | 16.9B | 17.6B | 10.2B | |
Non Current Liabilities Total | 11.4B | 11.6B | 12.4B | 12.1B | 12.2B | 6.1B | |
Inventory | 97.9M | 111.6M | 107.4M | 109.1M | 143.1M | 83.8M | |
Other Current Assets | 173.2M | 253.2M | 165.6M | 173.7M | 187.2M | 104.4M | |
Other Stockholder Equity | 749.0M | 597.1M | 540.3M | 606.9M | 509.8M | 367.2M | |
Total Liab | 13.8B | 14.1B | 14.8B | 14.7B | 14.9B | 7.7B | |
Total Current Assets | 3.7B | 3.1B | 3.2B | 3.2B | 3.1B | 2.6B | |
Short Term Debt | 474.6M | 538.0M | 573.4M | 626.8M | 517.7M | 543.6M | |
Intangible Assets | 135.7M | 166.6M | 177.7M | 182.7M | 203.2M | 193.1M | |
Property Plant And Equipment Gross | 6.3B | 6.4B | 11.1B | 11.2B | 11.3B | 11.9B | |
Accumulated Other Comprehensive Income | (47.5M) | (66.2M) | (139.2M) | (69.2M) | (52.1M) | (54.7M) | |
Common Stock Total Equity | 126K | 110K | 97K | 90K | 103.5K | 149.1K | |
Common Stock | 126K | 110K | 97K | 90K | 89K | 147.1K | |
Other Liab | 738.4M | 959.7M | 950.1M | 888.0M | 1.0B | 1.1B | |
Other Assets | 91.5M | 79.5M | 136.7M | 1K | 725.9M | 762.2M | |
Long Term Debt | 8.0B | 7.9B | 8.7B | 8.7B | 8.3B | 6.2B | |
Property Plant Equipment | 3.5B | 3.5B | 3.5B | 3.3B | 3.7B | 2.0B | |
Good Will | 6.8B | 6.9B | 7.0B | 7.1B | 7.1B | 6.3B | |
Short Term Investments | 11.6M | 20.1M | 22.3M | 77.7M | 11.6M | 11.0M | |
Net Tangible Assets | (3.6B) | (4.4B) | (5.0B) | (5.2B) | (4.7B) | (4.9B) | |
Noncontrolling Interest In Consolidated Entity | 185.8M | 183.2M | 180.6M | 163.6M | 147.2M | 139.8M | |
Retained Earnings Total Equity | 1.4B | 852.5M | 354.3M | 174.5M | 157.0M | 149.2M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether DaVita HealthCare offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of DaVita HealthCare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Davita Healthcare Partners Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Davita Healthcare Partners Stock:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DaVita HealthCare Partners. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DaVita HealthCare. If investors know DaVita will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DaVita HealthCare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.05) | Earnings Share 9.28 | Revenue Per Share 145.293 | Quarterly Revenue Growth 0.046 | Return On Assets 0.0694 |
The market value of DaVita HealthCare is measured differently than its book value, which is the value of DaVita that is recorded on the company's balance sheet. Investors also form their own opinion of DaVita HealthCare's value that differs from its market value or its book value, called intrinsic value, which is DaVita HealthCare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DaVita HealthCare's market value can be influenced by many factors that don't directly affect DaVita HealthCare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DaVita HealthCare's value and its price as these two are different measures arrived at by different means. Investors typically determine if DaVita HealthCare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DaVita HealthCare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.